American Century Companies’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.8M Sell
209,394
-32,114
-13% -$983K ﹤0.01% 1686
2026
Q1
$8.05M Buy
241,508
+37,110
+18% +$1.24M ﹤0.01% 1558
2025
Q4
$7.07M Buy
204,398
+17,676
+9% +$564K ﹤0.01% 1597
2025
Q3
$5.08M Buy
186,722
+72,078
+63% +$1.74M ﹤0.01% 1703
2025
Q2
$2.41M Buy
114,644
+102,736
+863% +$1.97M ﹤0.01% 1970
2025
Q1
$195K Buy
+11,908
New +$254K ﹤0.01% 2765
2024
Q3
– Sell
-8,541
Closed -$300K – 2921
2024
Q2
$300K Sell
8,541
-1,392
-14% -$55.1K ﹤0.01% 2633
2024
Q1
$436K Sell
9,933
-776
-7% -$33.4K ﹤0.01% 2495
2023
Q4
$381K Sell
10,709
-28,946
-73% -$864K ﹤0.01% 2471
2023
Q3
$1.07M Buy
39,655
+10,640
+37% +$270K ﹤0.01% 1963
2023
Q2
$682K Buy
29,015
+11,992
+70% +$247K ﹤0.01% 2092
2023
Q1
$230K Buy
17,023
+5,111
+43% +$85.1K ﹤0.01% 2376
2022
Q4
$216K Buy
+11,912
New +$200K ﹤0.01% 2315

Other funds holding IDYA

American Century Companies's IDYA Position: Q2 2026 in Review

American Century Companies reduced its IDEAYA Biosciences (IDYA) stake by 13% in Q2 2026, selling an estimated $983K and leaving 209,394 shares worth $7.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

American Century Companies first reported a position in IDYA in Q4 2022 and has held it in 13 quarters since. The position peaked at $8.05M in Q1 2026. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • American Century Companies held 209,394 shares of IDEAYA Biosciences worth $7.8M as of Q2 2026.
  • American Century Companies sold 32,114 IDEAYA Biosciences shares in Q2 2026, an estimated $983K.
  • IDEAYA Biosciences made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1686 holding.
  • American Century Companies first reported a position in IDEAYA Biosciences in Q4 2022 and has held it in 13 quarters since.
  • American Century Companies's IDEAYA Biosciences position peaked at $8.05M in Q1 2026.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.